InsiderTrades.com logo

TLX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $996,738.45
Insider Selling (Last 12 Months): $0.00

Telix Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Telix Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Telix Pharmaceuticals Share Price & Price History

Current Price: $11.11
Price Change: ▲ Price Increase of +0.07 (0.63%)
As of 05/6/2026 04:00 PM ET

This chart shows the closing price history over time for TLX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Telix Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/29/2026Christian BehrenbruchCEOBuy33,435$14.87$497,178.4520,742,935View SEC Filing Icon  
4/28/2026Christian BehrenbruchCEOBuy34,500$14.48$499,560.0020,709,500View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Telix Pharmaceuticals (NASDAQ:TLX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TLX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Telix Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/27/2026Private Advisor Group LLC174,415$1.67M0.0%+276.3%0.051%Search for SEC Filing on Google Icon
2/18/2026Vident Advisory LLC27,249$0.20M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd11,820$89K0.0%N/A0.003%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd36,828$0.28M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/18/2026OLD Mission Capital LLC14,799$0.11M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC19,733$0.15M0.0%-90.0%0.006%Search for SEC Filing on Google Icon
2/17/2026Lazard Asset Management LLC250,517$1.88M0.0%+118.6%0.074%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC36,582$0.27M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP46,658$0.35M0.0%-3.9%0.014%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC40,042$0.30M0.0%-45.1%0.012%Search for SEC Filing on Google Icon
2/12/2026Portland Investment Counsel Inc.266,200$2.06M0.6%+108.0%0.079%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.25,355$0.24M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC196,741$1.88M0.0%N/A0.058%Search for SEC Filing on Google Icon
11/14/2025Lazard Asset Management LLC114,624$1.10M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/14/2025Portland Investment Counsel Inc.128,000$1.23M0.3%N/A0.038%Search for SEC Filing on Google Icon
11/13/2025Private Advisor Group LLC42,112$0.40M0.0%+67.3%0.012%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.25,355$0.24M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers2,579$25K0.0%+117.3%0.001%Search for SEC Filing on Google Icon
8/15/2025IHT Wealth Management LLC13,240$0.21M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC35,103$0.56M0.0%N/A0.010%Search for SEC Filing on Google Icon
8/13/2025Russell Investments Group Ltd.60,301$0.98M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/5/2025Pier Capital LLC188,992$3.04M0.5%N/A0.056%Search for SEC Filing on Google Icon
7/25/2025Vanguard Personalized Indexing Management LLC18,475$0.30M0.0%N/A0.005%Search for SEC Filing on Google Icon
7/24/2025Blair William & Co. IL13,500$0.22M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/9/2025ABC Arbitrage SA26,939$0.45M0.1%N/A0.008%Search for SEC Filing on Google Icon
5/5/2025Private Advisor Group LLC10,140$0.17M0.0%N/A0.003%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Telix Pharmaceuticals logo
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.
Read More on Telix Pharmaceuticals

Today's Range

Now: $11.11
Low: $10.90
High: $11.15

50 Day Range

MA: $9.10
Low: $6.55
High: $11.24

52 Week Range

Now: $11.11
Low: $6.28
High: $18.49

Volume

87,368 shs

Average Volume

208,018 shs

Market Capitalization

$3.77 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.08

Who are the company insiders with the largest holdings of Telix Pharmaceuticals?

Telix Pharmaceuticals' top insider shareholders include:
  1. Christian Behrenbruch (CEO)
Learn More about top insider investors at Telix Pharmaceuticals.

Who are the major institutional investors of Telix Pharmaceuticals?

Telix Pharmaceuticals' top institutional investors include:
  1. Private Advisor Group LLC — 0.05%
Learn More about top institutional investors of Telix Pharmaceuticals stock.

Which institutional investors are buying Telix Pharmaceuticals stock?

In the previous quarter, TLX stock was purchased by institutional investors including:
  1. Private Advisor Group LLC